Literature DB >> 3350290

Ileal excretion of bile acids: comparison with biliary bile composition and effect of ursodeoxycholic acid treatment.

A Stiehl1, R Raedsch, G Rudolph.   

Abstract

The amount of bile acid excreted via an ileostomy at the end of the ileum should give an estimate of the amount of bile acid transported to the colon. In the present study, 8 patients with ileostomies at the end of the ileum but without disease or resection of the small intestine excreted 1690 +/- 205 mumol/day (mean +/- SEM) of bile acids from the ileostomies. In comparison with duodenal bile, cholic acid was increased at the end of the ileum and chenodeoxycholic acid decreased; in addition, bile acid sulfates were increased and bile acid glucuronides were decreased. When ursodeoxycholic acid, a bile acid that decreases biliary cholesterol saturation and dissolves gallstones, was administered at a dose of 500 mg to each subject, 59% +/- 8% (mean +/- SEM) of this bile acid was excreted within 24 h from the ileostomies. It is apparent from these studies that absorption of ursodeoxycholic acid from the small intestine is slower than previously anticipated and involves the entire small intestine and probably also the colon.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3350290     DOI: 10.1016/0016-5085(88)90013-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

Review 1.  Ursodeoxycholic acid in the treatment of liver diseases.

Authors:  S Saksena; R K Tandon
Journal:  Postgrad Med J       Date:  1997-02       Impact factor: 2.401

2.  Influence of cholestasis on absorption of ursodeoxycholic acid.

Authors:  P Sauer; C Benz; G Rudolph; P Klöters-Plachky; W Stremmel; A Stiehl
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

Review 3.  Clinical pharmacokinetics of therapeutic bile acids.

Authors:  A Crosignani; K D Setchell; P Invernizzi; A Larghi; C M Rodrigues; M Podda
Journal:  Clin Pharmacokinet       Date:  1996-05       Impact factor: 6.447

4.  Protective effect of tauroursodeoxycholate against chenodeoxycholate-induced damage to cultured rabbit gastric cells.

Authors:  S Ota; H Tsukahara; A Terano; Y Hata; H Hiraishi; H Mutoh; T Sugimoto
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

5.  Effect of colitis and ileoanal pouch on biliary enrichment of ursodeoxycholic acid in primary sclerosing cholangitis.

Authors:  D Rost; G Rudolph; P Kloeters-Plachky; A Stiehl
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

6.  Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration.

Authors:  A Lanzini; M G De Tavonatti; B Panarotto; S Scalia; A Mora; F Benini; O Baisini; F Lanzarotto
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

7.  Cholic acid and ursodeoxycholic acid therapy in primary biliary cirrhosis. Changes in bile acid patterns and their correlation with liver function.

Authors:  S Güldütuna; M Leuschner; N Wunderlich; A Nickel; S Bhatti; K Hübner; U Leuschner
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Treatment of primary sclerosing cholangitis.

Authors:  Daniel Rost; Hasan Kulaksiz; Adolf Stiehl
Journal:  Curr Treat Options Gastroenterol       Date:  2007-04

9.  Intestinal absorption of unconjugated dihydroxy bile acids: non-mediation by the carrier system involved in long chain fatty acid absorption.

Authors:  W Stremmel; A F Hofmann
Journal:  Lipids       Date:  1990-01       Impact factor: 1.880

10.  Rapid cholesterol nucleation time and cholesterol gall stone formation after subtotal or total colectomy in humans.

Authors:  I Makino; K Chijiiwa; H Higashijima; S Nakahara; M Kishinaka; S Kuroki; R Mibu
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.